After the intravenous infusion of N-hydroxysuccinimido biotin into dogs, 80.6% 2 9.7% (n = 5 ) of platelets were covalently labeled with biotin. The in vivo survival of the biotinylated platelets was monitored by flow cytometry and was normal as compared with previous reports for dog platelets. The ability of the biotinylated platelets to be activated was analyzed by measuring the expression of cell-surface P-selectin after incubation with graded concentrations of thrombin. When P-selectin expression was examined 3 hours after labeling, biotinylated platelets were indistinguishable from the nonlabeled population of platelets, indicating that biotinylation did not adversely HE LIFE SPAN of platelets is relatively short, eg, 10 days in humans' and 6 days in During that time period, platelets may be consumed by hemostatic processes or circulate until recognized as senescent, although previous studies indicate that the majority of platelets live to the end of their predetermined life span.'*2 A long-standing question related to the platelet life span concerns the functional capabilities of platelets as they age. For example, numerous investigators have suggested that younger platelets are more hemostatically active than older platelet^,^-^ although relatively little definitive data are available that directly address the functional competence of aged platelets.
During that time period, platelets may be consumed by hemostatic processes or circulate until recognized as senescent, although previous studies indicate that the majority of platelets live to the end of their predetermined life span.'*2 A long-standing question related to the platelet life span concerns the functional capabilities of platelets as they age. For example, numerous investigators have suggested that younger platelets are more hemostatically active than older platelet^,^-^ although relatively little definitive data are available that directly address the functional competence of aged platelets.
Previous reports have examined platelet aging and have described often contradictory findings. For example, the density of platelets has been argued to increase"" or de- reas se^*""^ during aging, although some of these discrepancies may be related to species differences. Additionally, the size,15 sialic acid content, 16 IgG content of a-gran~les,'~ thrombin reactivity,18 total membrane ont tent,^.'',^^ collagen adheren~e,~ glycolytic enzyme HLA content,22 and serotonin content' have all been proposed to vary with age of the platelet. However, robust data concerning the physical or biochemical state of aged platelets have been difficult to obtain, and a primary obstacle has been the identification and isolation of aged platelets. Previous studies have relied on two general approaches to isolate aged platelets, either experimental manipulation of the animals to generate young cohorts of platelets that are monitored as a function of time'5,'8~20~2' or physical separation techniques, such as density fra~tionation.~~'~,~~,~~ These methodologies are complicated by a number of factors. For example, manipulation of experimental animals is quite reliable for generating young cohorts of platelet^,'^^'^ but with time these cohorts are increasingly contaminated by the continued synthesis of platelets and, therefore, are not useful for the study of platelet aging. Those reports relying on density fractionation are compromised by the fact that it is not clear whether the density differences between young and old platelets are great enough to allow effective separation of cells even if a clear relationship does exist between cell age and density. Similar problems have plagued the red blood cell aging field with regard to the use of density fractionation for obtaining aged erythrocyte^.^^ affect the cells. On consecutive days after biotinylation, the thrombin dose-response curves for biotinylated and nonbiotinylated platelets were repeated, and as the biotinylatedplatelets aged, they became less responsive to thrombin.
On days 3,4, and 5, the thrombin ECm for the aged, biotinylated platelets as compared with the total population of platelets was 136%, 150%. and 178%. respectively. Increasing age clearly impairs the reactivity of platelets towards thrombin as quantitated by the expression of cellsurface P-selectin. 0 1994 by The American Society of Hematology.
In this report, we have used a new approach for the identification of aged platelets in which the platelets are biotinylated in vivo by reaction with N-hydroxysuccinimido biotin (NHS-biotin) and then monitored by flow ~y t o m e t r y .~~ Biotinylation of platelets permits the unambiguous identification of aged cells as well as the opportunity to examine functional capabilities throughout the life span of the labeled platelets. In this report, we document that the capacity of platelets to be activated in response to thrombin declines with platelet age.
propanol and mixed well. The suspension was centrifuged at I ,500g for 15 minutes at 4°C and the supernatant was discarded. The pellet was dissolved in 300 mL of 140 mmol/L NaCI. IO mmol/L Tris. pH 7.4, and then further purified according to method no. 1 .27 Bujers. The buffers used were phosphate-buffered saline (PBS; 150 mmol/L NaCI, 10 mmol/L NaH2P04, pH 7.4, with NaOH); acid citrate dextrose (ACD) (38. I mmol/L citric acid, 74.8 mmol/L Na3 citrate, 136 mmol/L glucose; and buffered saline glucose citrate (BSGC; 129 mmol NaCI, 13.6 mmol/L Na3 citrate, 11.1 mmol/ L glucose, 1.6 mmol/L KH2P04, 8.6 mmol/L NaH2P04, pH 7.3).
When BSGC was used at pH 6.5, the pH was adjusted with citric acid.
Platelet hiotinylatiun. Adult Beagle dogs (Hazelton Research Products, Cumberland, VA) were obtained and housed according to regulations of the Institutional Animal Care and Use Committee of the University of Oklahoma Health Sciences Center (accredited by the American Association for Accreditation of Laboratory Animal Care). Dog platelets were biotinylated in vivo by the intravenous infusion of NHS-biotin, similar to procedures described for rabbit biotinylation." Specifically, 7.7 mg NHS-biotin/kg body weight was dissolved in DMSO at 20 mg/mL. Immediately before infusion, the NHS-biotin in DMSO wasdiluted into 25 mL ofsterile saline. This aqueous solution was infused into a front leg vein via a 21-gauge butterfly needle attached to a syringe pump.*' The total infusion required 8 to 12 minutes.
Thrombin activation of platelets. Blood samples were drawn from the dog before and after biotinylation to determine the thrombin reactivity of biotinylated and nonbiotinylated platelets. The level of activation was monitored by the expression of P-selectin on the platelet surface using the anti-P-selectin MoAb. G5; biotinylation was monitored by the binding of PE-SA. Specifically, 4.5 mL of dog blood was drawn into a IO-mL syringe containing 0.5 mL ACD and 4 pg of PGEi. The 5-mL blood sample was washed by adding it to 45 mL of BSGC, pH 6.5, and centrifuging at 1,250s for 18 minutes at room temperature; greater than 99% of all platelets were pelleted under these conditions. The pellet was resuspended in BSGC, pH 7.3, to a final volume of 5 mL. Eight tubes were prepared containing I O pL of washed blood, 40 pL of graded concentrations of bovine thrombin in 0. I % bovine serum albumin (BSA) and 950 pL BSGC, pH 7.3, with 60 pg FITC-G5. The tubes were incubated at 37°C for 10 minutes. The reaction was stopped by adding I mL of 0.6% formaldehyde. After fixing the samples for 10 minutes at room temperature, I O mL of BSGC, pH 7.3, with 0.1% BSA was addedandthesamplewascentrifugedat 1,250gfor 18minutes.The pellet was resuspended in 1 mL of BSGC, pH 7.3. Ten micrograms of FITC-goat-antimouse IgG was added to amplify the G5 signal. This mixture was incubated at room temperature for 15 minutes and the samples were washed again with BSGC as detailed above. The pellet was resuspended in 1 mL of BSGC, pH 7.3. One hundred microliters of each suspension was then added to 2 pg of PE-SA and incubated at room temperature for 15 minutes. Each sample was diluted with 900 pL of BSGC, pH 7.3, and analyzed by flow cytometry.
Flow cytometric analysis of biorinylatecl platelets and P-selectin surjacr expression. Flow cytometry was performed on a Becton Dickinson FACScan equipped with an argon-ion laser emitting at 488 nm (Becton Dickinson, Mountain View, CA). For two-color analyses (FITC-G5 and PE-SA), the following log scale settings were used: FSC, EOO; SSC, 332 V; FL, . 520 V; FL2, 520 V; FSC threshold, 176 V; and compensation, FL, -%FL2 = 0.870, FL2 -%FL, = 22.5. Platelets were identified by their characteristic forward and side light scatter; 10,000 events were collected for each sample. To verify that only platelets were being measured in the two-color experiments outlined above, a three-color experiment was performed that allowed the fluorescent detection of the platelets' surface proteins as well as of P-selectin and biotin. The only difference from the experiments detailed above is the inclusion of an FITC-labeled, chicken-antidog platelet antibody to identify platelets. To permit detection of P-selectin, unlabeled G5 MoAb was incubated with the activated platelets as described above and a phycoerythrin-labeled, goat-antimouse IgG heteroserum was used to allow fluorescent measurement of the bound MoAb. Streptavidin-Tricolor was used to detect biotinylated platelets. For three-color analyses (FITCchicken-antidog platelet IgG, PE-goat-antimouse IgG/GS, and streptavidin-Tricolor), the same settingsasdetailed above were used plus an FL3 voltage of 600 V with FL2 -%FL3 = 1 .O% and FL, -Statisfical analwes. Thrombin dose-response curves were analyzed with Immuno-Fit (Beckman Biomek, Fullerton. CA); the thrombin concentration inducing half-maximal activation is expressed as the ECSo. A double-sided, Student's t-test was performed to test for changes in the thrombin ECSo values. %FL2 = 20.0%.
RESULTS
A previous study showed that dog platelets biotinylated in vitro have a normal in vivo survival and participate normally in in vitro aggregation processes. 25 In this report, the platelet biotinylation technique is extended by performing the labeling reaction in vivo. Under these circumstances, a majority of the platelets, 80.6% f 9.7% (mean f I SD; n = 5), are biotinylated and can be easily identified by flow cytometry using PE-SA. The survival curves after in vivo biotinylation were found to agree with the survivals observed after in vitro biotinylation of dog platelets (Fig 1) .
For The normal survival of biotinylated platelets allows this system to be used to study platelet aging. For example, 5 days after in vivo biotinylation, the only biotinylated platelets remaining are between 5 and 6 days old, whereas none of the platelets less than 5 days old are biotinylated. As a result, functional analysis of biotinylated platelets at various times after labeling will permit an unequivocal examination of aged platelets. To determine the thrombin responsiveness of aging platelets, blood was drawn daily after biotinylation and platelets were incubated with increasing concentrations of thrombin for 10 minutes at 37'C. The degree of activation was monitored by the surface expression of P-selectin, an a-granule membrane protein found on the cell surface only afier secreti01-1~~; P-selectin was identified with an FITC-labeled, MoAb, G5. As shown in Fig 2, a saturating dose of thrombin (0.5 U/mL) results in 89.4% of the platelets expressing surface P-selectin (Fig 2A) , whereas only 2.2% of the unstimulated platelets are initially positive for P-selectin (Fig 2B) . Also shown in Fig 2 is the assessment of surface biotinylation (Fig 2C) , which, in conjunction with P-selectin measurements, allows the level of activation for B C both the biotinylated (aged) and nonbiotinylated (young) platelets to be monitored.
A complete dose-response curve for thrombin activation of dog platelets over a range from 0.008 to 0.5 U/mL of thrombin is shown in Fig 3. For this experiment, blood was drawn 3 hours after in vivo biotinylation in which 73% of all platelets were labeled. The thrombin dose-response curves for the whole population, the biotinylated platelets, and the nonbiotinylated platelets were found to be identical, showing that biotinylation itself does not affect the platelet response to thrombin. A typical analysis of aged platelets responding to thrombin is shown in Fig 4. In this example, platelets were studied 5 days after biotinylation, at which time only 2 1 % of the platelets were biotinylated; these cells were within 24 hours of their expected death. The thrombin ECSo was 0.0593 U/ mL for the whole population, 0.0491 U/mL (83% of control) for the nonbiotinylated population, and 0.1003 (169% of control) for the biotinylated platelets, indicating that the aged platelets were activated less readily by low concentrations of thrombin. An analysis of the thrombin ECN for all 5 days after biotinylation for a representative dog is shown in Fig 5. The biotinylated platelets have an increasing ECso for thrombin as the mean age of this population increases, and the nonbiotinylated platelets have a modestly decreased EC5,, for thrombin during this time frame, as would be expected. Table 1 lists the average thrombin ECso values for days 3 through 5 for all five dogs studied. On day 5, the thrombin ECso for the aged platelets was increased to 178% of that for the control, unfractionated population.
DISCUSSION
Age-dependent changes in the circulating platelet have been refractory to investigation for the simple technical reason that it has not been possible to isolate or identify aged platelets. This report describes the use of in vivo biotinylation of platelets to overcome this obstacle. The biotinylated platelets can be readily identified by flow cytometry using PE-SA and were found to have a life span similar to that shown for "lIn-oxine-labeled or in vitro biotinylated plateletsz5 (Fig 1) . In vivo biotinylation has been used successfully for several years in rabbits for labeling erythrocytes,** and these studies show that dog platelets can also be labeled with this procedure. With a normal life span and a means of detection, biotinylated platelets can be used to study platelet aging.
Biotinylation was performed in vivo by intravenous infusion of NHS-biotin, resulting in approximately 80% of all circulating platelets being biotinylated. The incomplete biotinylation of the platelet population does not impede exThrombin (U/ml) The ECW for thrombin was determined for the total population of platelets, the nonbiotinylated platelets, and the biotinylated plateletsfor days 3, 4, and 5 after biotinylation. Data are calculated relative to thrombin ECSo for the total population for each individual sample as described in the legend to Fig 5. Data represent the mean k 1 SD, One additional aspect of the in vivo biotinylation that needs to be addressed is whether megakaryocytes are labeled and result in the subsequent release of biotinylated platelets over the next few days. To address this question, a marrow aspirate was obtained on one dog 2 hours after biotinylation, and the megakaryocytes were examined for PE-SA binding under a fluorescent microscope. The cells were not fluorescent under conditions where biotinylated platelets were readily detectable, suggesting that biotinylation of megakaryocytes in the marrow does not occur under the conditions used here.
The first parameter to be examined with this biotinylation methodology was the response ofaged platelets to thrombin, which is monitored by the expression of cell-surface P-selectin.29 As shown in Fig 3, varying the thrombin concentration over a range of 0.008 to 0.5 U/mL results in steadily increasing numbers of platelets being activated. As shown previously, suboptimal doses of thrombin result in a portion of the platelets responding completely to the agonist and the remainder not responding at all.29 As a result, the data for the thrombin dose-response curves are expressed as the percentage of platelets that are positive for P-selectin.
In a control experiment, thrombin dose-response curves were performed 3 hours after in vivo biotinylation to show that biotinylation per se did not affect the response of platelets to thrombin (Fig 3) . The curves for the biotinylated and nonbiotinylated platelets were indistinguishable. When additional samples were examined at various times after biotinylation, the aging, biotinylated platelets showed a progressively lower sensitivity to thrombin. An example is shown in Fig 4 in which blood drawn 5 days after biotinylation showed a thrombin EC50 for the aged platelets that was 169% of that observed for the total population; the nonbiotinylated population had a thrombin ECso that was 83% of the total population. When other time points were examined, it was clear that the thrombin ECso increases with time for the aging platelets (Fig 5 and Table 1 ).
The mechanism for this change in thrombin responsiveness is not clear. There may be either a decrease in the number of functional thrombin receptors on the aged platelet or an age-related alteration in the second messenger system for the thrombin receptor. Concerning the first of these possibilities, a decrease in the number of functional thrombin receptors on aging platelets could possibly occur through three mechanisms. The first mechanism would be a loss of platelet membrane during aging with concomitant loss of active thrombin receptors; such a nonspecific loss of membrane has been reported for rabbit platelets.19 A second mechanism would be a time-dependent denaturation of the thrombin receptor analogous to the observed loss of enzyme activity in aging erythrocytes," another mature cell not capable of protein synthesis. The third possible mechanism would be that the thrombin receptor is enzymatically cleaved by thrombin during its in vivo aging but not at a rate sufficient to produce activation ofthe latel let.^' Because the thrombin activation pathway involves a proteolytic cleavage ofthe thrombin re~eptor,'~ this type ofactivation would result in irreversible loss of functional thrombin receptors. The other possible defect in the aged platelet concerns the second messenger system of the thrombin receptor.33 The term second messenger is used here in very broad terms ranging from increases in cytoplasmic calcium to the membrane fusion events associated with secretion after thrombin activation. It should be noted that the total percentage of activatable platelets was the same for both the aged and control populations and that the total level of surface-expressed P-selectin was similar for both populations as judged by the total fluorescence achievable upon binding FITC-G5. These latter observations suggest that the level of P-selectin has not decreased significantly during aging and that the cellular machinery necessary to fuse a-granule membranes with the cell surface is also intact. Additional experiments are in progress to determine the defect in aged platelets responsible for this apparent decreased responsiveness to thrombin.
The biotinylation technique described here allows an unambiguous evaluation oftime-dependent changes in the circulating platelet and should facilitate the resolution of many long-standing questions concerning the aging of platelets.
